GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (FRA:IL3) » Definitions » Cyclically Adjusted FCF per Share

Integra Lifesciences Holdings (FRA:IL3) Cyclically Adjusted FCF per Share : €1.53 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Integra Lifesciences Holdings's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.003. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €1.53 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Integra Lifesciences Holdings's average Cyclically Adjusted FCF Growth Rate was 6.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 21.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 13.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Integra Lifesciences Holdings was 89.50% per year. The lowest was -2.90% per year. And the median was 8.90% per year.

As of today (2024-06-08), Integra Lifesciences Holdings's current stock price is €28.40. Integra Lifesciences Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €1.53. Integra Lifesciences Holdings's Cyclically Adjusted Price-to-FCF of today is 18.56.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Integra Lifesciences Holdings was 75.38. The lowest was 15.38. And the median was 45.36.


Integra Lifesciences Holdings Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Integra Lifesciences Holdings's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Cyclically Adjusted FCF per Share Chart

Integra Lifesciences Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 0.77 1.07 1.46 1.51

Integra Lifesciences Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 1.50 1.55 1.51 1.53

Competitive Comparison of Integra Lifesciences Holdings's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Integra Lifesciences Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integra Lifesciences Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Integra Lifesciences Holdings's Cyclically Adjusted Price-to-FCF falls into.



Integra Lifesciences Holdings Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Integra Lifesciences Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.003/131.7762*131.7762
=0.003

Current CPI (Mar. 2024) = 131.7762.

Integra Lifesciences Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.079 100.560 0.104
201409 0.291 100.428 0.382
201412 0.160 99.070 0.213
201503 0.364 99.621 0.481
201506 0.241 100.684 0.315
201509 0.180 100.392 0.236
201512 0.138 99.792 0.182
201603 0.166 100.470 0.218
201606 0.337 101.688 0.437
201609 0.438 101.861 0.567
201612 -0.173 101.863 -0.224
201703 0.235 102.862 0.301
201706 0.181 103.349 0.231
201709 0.395 104.136 0.500
201712 -0.023 104.011 -0.029
201803 0.266 105.290 0.333
201806 0.166 106.317 0.206
201809 0.621 106.507 0.768
201812 0.173 105.998 0.215
201903 0.137 107.251 0.168
201906 0.317 108.070 0.387
201909 -0.152 108.329 -0.185
201912 0.699 108.420 0.850
202003 -0.007 108.902 -0.008
202006 0.272 108.767 0.330
202009 0.630 109.815 0.756
202012 0.501 109.897 0.601
202103 0.615 111.754 0.725
202106 0.823 114.631 0.946
202109 0.751 115.734 0.855
202112 0.431 117.630 0.483
202203 0.326 121.301 0.354
202206 0.646 125.017 0.681
202209 0.716 125.227 0.753
202212 0.800 125.222 0.842
202303 0.141 127.348 0.146
202306 0.145 128.729 0.148
202309 0.161 129.860 0.163
202312 0.402 129.419 0.409
202403 0.003 131.776 0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Integra Lifesciences Holdings  (FRA:IL3) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Integra Lifesciences Holdings's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=28.40/1.53
=18.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Integra Lifesciences Holdings was 75.38. The lowest was 15.38. And the median was 45.36.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Integra Lifesciences Holdings Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Integra Lifesciences Holdings (FRA:IL3) Business Description

Traded in Other Exchanges
Address
1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings (FRA:IL3) Headlines

No Headlines